...
首页> 外文期刊>Journal of cataract and refractive surgery >Late-onset progression of keratoconus after therapy with selective tissue estrogenic activity regulator
【24h】

Late-onset progression of keratoconus after therapy with selective tissue estrogenic activity regulator

机译:选择性组织雌激素活性调节剂治疗后角蛋白的晚期进展

获取原文
获取原文并翻译 | 示例

摘要

We describe the association of rapid progression of keratoconus in a 49-year-old woman on selective tissue estrogenic activity regulator (STEAR) therapy for endometriosis. Approximately 4 months after initiation of therapy with STEAR therapy and 3 months after ovariectomy, Scheimpflug images showed a massive increase in the previously stable ectasia. During this period, the maximum increase in the keratometry values was 2.7 diopters (D) in the right eye and 3.8 D in the left eye. Corneal crosslinking (CXL) was performed in both eyes. This resulted in excessive flattening of 5.5 D in the right eye and 6.1 D in the left eye at 9 months postoperatively. Patients having STEAR therapy must be monitored closely for corneal changes. (C) 2018 ASCRS and ESCRS
机译:我们描述了一个49岁女性在选择性组织雌激素活性调节剂(STEAR)治疗的49岁女性中的快速进展协会,用于子宫内膜异位症。 大约4个月后在患有血糖治疗的治疗和卵巢切除术后3个月后,Scheimpflug图像显示出先前稳定的异位的巨大增加。 在此期间,在右眼中的静脉测量值的最大增加是2.7屈光度(d),左眼3.8d。 在双眼中进行角膜交联(CXL)。 这导致右眼5.5d的过度扁平化,术后9个月在右眼和6.1d中过高。 必须对角膜变化密切监测具有血糖治疗的患者。 (c)2018年ASCRS和ESCRS

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号